Pairwise sees ‘dramatic uptick’ in CRISPR licensing as gene editing moves beyond row crops
Pairwise has seen a surge in licensing deals for its gene editing platform over the past 12-18 months and now has 25 licensees, says COO Ian Miller, PhD.
Pairwise has seen a surge in licensing deals for its gene editing platform over the past 12-18 months and now has 25 licensees, says COO Ian Miller, PhD.
Quorn’s new protein bites reach a new set of consumers and command higher price points and margins, says the alt meat firm.